发明名称 |
METHODS FOR TREATING RELAPSING FORMS OF MULTIPLE SCLEROSIS |
摘要 |
Disclosed herein are anti-RGMa antibodies and methods of using these antibodies to treat multiple sclerosis, including relapsing forms of multiple sclerosis such as relapsing-remitting multiple sclerosis or relapsing-secondary progressive multiple sclerosis. |
申请公布号 |
US2017073420(A1) |
申请公布日期 |
2017.03.16 |
申请号 |
US201615261633 |
申请日期 |
2016.09.09 |
申请人 |
AbbVie Inc. ;AbbVie Deutschland GmbH & Co. KG |
发明人 |
Greenberg Steven J.;Mueller Bernhard K.;Popp Andreas;Rosebraugh Matthew R.;Haig George M.;Lin Shao-Lee |
分类号 |
C07K16/28;A61K45/06;A61K39/395 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating a relapsing form of multiple sclerosis in a subject in need thereof, the method comprising administering a therapeutically effective amount of an antibody or antigen-binding fragment thereof that specifically binds Repulsive Guidance Molecule A (RGMa), wherein the antibody or antigen binding fragment comprises
(a) a variable heavy chain comprising a complementarity determining region (CDR)-1 comprising an amino acid sequence of SEQ ID NO:2, a CDR-2 comprising an amino acid sequence of SEQ ID NO:3, and a CDR-3 comprising an amino acid sequence of SEQ ID NO:4; and (b) a variable light chain comprising a CDR-1 comprising an amino acid sequence of SEQ ID NO:6, a CDR-2 comprising an amino acid sequence of SEQ ID NO:7, and a CDR-3 comprising an amino acid sequence of SEQ ID NO:8. |
地址 |
North Chicago IL US |